176 related articles for article (PubMed ID: 16625791)
21. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
23. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998.
Bobo JK; Lee NC; Thames SF
J Natl Cancer Inst; 2000 Jun; 92(12):971-6. PubMed ID: 10861308
[TBL] [Abstract][Full Text] [Related]
24. Contribution of clinical breast exam to cancer detection in women participating in a modern screening program.
Menes TS; Coster D; Coster D; Shenhar-Tsarfaty S
BMC Womens Health; 2021 Oct; 21(1):368. PubMed ID: 34666735
[TBL] [Abstract][Full Text] [Related]
25. Time to follow-up of an abnormal mammogram in women with diabetes: a population-based study.
Habeeb SY; Fung K; Fischer HD; Austin PC; Paszat L; Lipscombe LL
Cancer Med; 2016 Nov; 5(11):3292-3299. PubMed ID: 27709838
[TBL] [Abstract][Full Text] [Related]
26. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for failure to detect a cancer during clinical breast examinations (United States).
Bobo JK; Lawson HW; Lee NC
Cancer Causes Control; 2003 Jun; 14(5):461-8. PubMed ID: 12946041
[TBL] [Abstract][Full Text] [Related]
28. Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.
Habbous S; Homenauth E; Barisic A; Kandasamy S; Majpruz V; Forster K; Yurcan M; Chiarelli AM; Groome P; Holloway CMB; Eisen A
CMAJ Open; 2022; 10(2):E313-E330. PubMed ID: 35383035
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of clinical breast examination's abnormalities for breast cancer screening: cross-sectional study.
Malmartel A; Tron A; Caulliez S
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():1-6. PubMed ID: 30974372
[TBL] [Abstract][Full Text] [Related]
30. Screening clinical breast examination.
Jatoi I
Surg Clin North Am; 2003 Aug; 83(4):789-801. PubMed ID: 12875596
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
32. Management of women at increased risk for breast cancer: preliminary results from a new program.
Chart PL; Franssen E
CMAJ; 1997 Nov; 157(9):1235-42. PubMed ID: 9361645
[TBL] [Abstract][Full Text] [Related]
33. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma.
Olivotto IA; Gomi A; Bancej C; Brisson J; Tonita J; Kan L; Mah Z; Harrison M; Shumak R
Cancer; 2002 Apr; 94(8):2143-50. PubMed ID: 12001110
[TBL] [Abstract][Full Text] [Related]
34. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.
Halapy EE; Chiarelli AM; Klar N; Knight J
J Med Screen; 2004; 11(1):32-8. PubMed ID: 15006112
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer mortality in relation to clinical breast examination and breast self-examination.
Weiss NS
Breast J; 2003; 9 Suppl 2():S86-9. PubMed ID: 12713502
[TBL] [Abstract][Full Text] [Related]
36. How reassuring is a normal breast ultrasound in assessment of a screen-detected mammographic abnormality? A review of interval cancers after assessment that included ultrasound evaluation.
Bennett ML; Welman CJ; Celliers LM
Clin Radiol; 2011 Oct; 66(10):928-39. PubMed ID: 21718976
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of abnormal mammography results and palpable breast abnormalities.
Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
[TBL] [Abstract][Full Text] [Related]
38. Earlier detection of breast cancer by surveillance of women at familial risk.
Tilanus-Linthorst MM; Bartels CC; Obdeijn AI; Oudkerk M
Eur J Cancer; 2000 Mar; 36(4):514-9. PubMed ID: 10717529
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Health Promot Chronic Dis Prev Can; 2018 Oct; 38(10):358-367. PubMed ID: 30303656
[TBL] [Abstract][Full Text] [Related]
40. Contradictions in women's health care provision: a case study of attendance for breast cancer screening.
Ross NA; Rosenberg MW; Pross DC; Bass B
Soc Sci Med; 1994 Oct; 39(8):1015-25. PubMed ID: 7809655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
